The global breast reconstruction meshes market is set to experience substantial growth over the next decade. Market valuations are anticipated to soar from USD 606.4 million in 2024 to an impressive USD 1,047.1 million by 2034, reflecting a robust compound annual growth rate (CAGR) of 5.6%. This notable expansion underscores the rising demand and continuous advancements in breast reconstruction procedures.
One of the key drivers of this market growth is the significant shift towards less invasive surgical methods in breast reconstruction. These innovative techniques are designed to be less traumatic for patients, thereby enhancing recovery times and overall patient outcomes. A prominent example of such an advanced method is oncoplastic surgery. This approach seamlessly integrates oncological surgery with the principles of plastic surgery, enabling the removal of tumors while simultaneously preserving or reconstructing the breast shape. Oncoplastic surgery effectively minimizes the aesthetic impact of cancer treatment, offering patients a less distressing experience both physically and emotionally.
Report Sample Comprehensive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-19674
Endoscopic surgery utilizes small incisions and a camera to guide the surgeon, resulting in reduced tissue trauma, quicker recovery, and less post-operative pain. These techniques necessitate the use of advanced meshes that can be inserted and precisely positioned through minimal incisions, supporting tissue without extensive dissection. Implant-based reconstruction has evolved with techniques that reduce recovery times and improve aesthetic outcomes.
One notable advancement is the prepectoral implant placement, where implants are placed above the pectoral muscle, avoiding the pain and extended recovery associated with muscle manipulation in subpectoral placements. This method requires specialized meshes to securely hold the implant and ensure a natural contour. The two-stage reconstruction approach, involving a tissue expander followed by a permanent implant, also benefits from advanced mesh products. Meshes are used to cover and support both the expander and the final implant, enhancing stability and cosmetic outcomes during each stage of the reconstruction.
Advancements in surgical techniques for breast reconstruction have significantly improved the effectiveness, safety, and patient satisfaction associated with these procedures. These innovations have created a strong demand for advanced mesh products that can support and enhance the outcomes of these techniques. By providing structural support, promoting tissue integration, and enabling less invasive approaches, these meshes are crucial to the success of modern breast reconstruction surgeries.
Key Takeaways from the Market Study:
- By product, the synthetic mesh is going to garner a lucrative CAGR value of 3% through 2034, along with a 2024 market share value of 55.4%. Such a trend can be attributed to the versality of synthetic meshes in their application, allowing for use in various reconstruction techniques including implant-based and autologous tissue-based reconstructions.
- The material strength of synthetic meshes is designed to withstand the forces and tensions exerted on the reconstructed breast, providing long-term structural support
- By nature, the absorbable mesh is anticipated to hold a 8% market value share in 2024. As the absorbable nature of these meshes eliminates the need for a secondary surgical procedure to remove permanent mesh materials, such can be necessary in certain cases with non-absorbable meshes. In certain cases, where temporary support is needed during the initial healing and tissue stabilization phase, absorbable meshes serve as a useful tool.
- By application, implant-based reconstruction will hold the dominant segment share in terms of the market share value of 0% in 2024. The market has responded to the prevalence of implant-based reconstruction by offering a diverse range of meshes specifically designed to support and integrate with breast implants. These specialized meshes cater to the specific needs of implant-based reconstruction, further solidifying their market share.
- By end user, the hospitals dominated the market with the dominant share, accounting for 6% of the market share value in 2024. Hospitals are at the forefront of employing advanced surgical techniques for breast reconstruction, encompassing both implant-based and autologous tissue-based approaches. These advanced techniques involve the use of specific meshes tailored to support various reconstruction methods, thereby contributing to hospitals’ prominent role as end users.
- North America emerges as the primary region, acquiring a substantial value share of 1% in 2024. The United States, in particular, has one of the highest healthcare expenditures globally. The substantial spending on healthcare contributes to the accessibility of advanced and innovative therapies, including breast reconstruction.
“Continuous advancements in mesh technologies, such as the development of biocompatible materials and bioresorbable meshes are enhancing the outcomes of breast reconstruction surgeries,” says an analyst of Future Market Insights.
Request Customization Available: https://www.futuremarketinsights.com/customization-available/rep-gb-19674
Market Competition:
Many companies strategize to capture competitors or other companies that generate less revenue. Market players are spending high amounts on research and development for new products to expand their market share. For instance,
- In January 2024, RTI Surgical, an industry-leading contract development and manufacturing organization (CDMO) serving the regenerative medicine industry, announced that it has completed its acquisition of Cook Biotech Incorporated.
- In December 2023, Stryker one of the world’s leading medical technology companies, announced that it has executed a binding offer to Menix to acquire SERF SAS
Leading Breast Reconstruction Meshes Brands:
- SERAG-WIESSNER GmbH & Co. KG
- Novus Scientific
- PFM medical
- Allergan Aesthetics
- Cook Biotech
- MedSkin Solutions Dr. Suwelack AG
- Tutogen Medical GmbH
- Becton, Dickinson and Company
- RTI Surgical
- Stryker Corporation
- PolyNovo
- MTF Biologics
- Tissue Regenix
- Aziyo Biologics
- Advanced Biomedical Concept Srl
- Biomedica
A Comprehensive Full Report: https://www.futuremarketinsights.com/checkout/19674
Key Segments of Market Report
By Product:
As per product, the industry has been categorized into Synthetic Mesh- (Polypropylene, Polyester (Polyethylene Terephthalate, PET), Polytetrafluoroethylene (PTFE), Polyvinylidene Fluoride (PVDF) and Expanded Polytetrafluoroethylene (ePTFE). Biological Mesh- (Bovine [Bovine Pericardium, Bovine Collagen]), (Porcine [Porcine Skin, Porcine Small Intestine] & Human
By Nature:
This segment is further categorized into absorbable mesh, nonabsorbable mesh, resorbable surgical mesh and non resorbable surgical mesh
By Application:
Different applications include implant-based reconstruction, autologous tissue reconstruction, pre-pectoral reconstruction, sub-pectoral reconstruction, revision surgeries and congenital asymmetry/deformity surgery.
By End User:
The end user segment includes hospitals, ambulatory surgical centers, speciality clinics, comprehensive cancer centers, plastic surgery clinics and academic & research institutes
By Region:
Industry analysis has been carried out in key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube